Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30065780HIVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20011742HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20038570HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20031720HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20044332HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20060882HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20031102HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20068487HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS20068506HPVENSG00000010810.18protein_codingFYNYesNo2534P06241
TVIS50000025MLVENSG00000010810.18protein_codingFYNYesNo2534P06241
TCGA Plot Options
Drug Information
GeneFYN
DrugBank IDDB01254
Drug NameDasatinib
Target IDBE0000839
UniProt IDP06241
Regulation Typeinhibitor
PubMed IDs20072833; 32268657
CitationsLindauer M, Hochhaus A: Dasatinib. Recent Results Cancer Res. 2010;184:83-102. doi: 10.1007/978-3-642-01222-8_7.@@Lee D, Park YH, Lee JE, Kim HS, Min KY, Jo MG, Kim HS, Choi WS, Kim YM: Dasatinib Inhibits Lyn and Fyn Src-Family Kinases in Mast Cells to Suppress Type I Hypersensitivity in Mice. Biomol Ther (Seoul). 2020 Sep 1;28(5):456-464. doi: 10.4062/biomolther.2020.013.
GroupsApproved; Investigational
Direct ClassificationAromatic anilides
SMILESCC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1
PathwaysDasatinib Inhibition of BCR-ABL
PharmGKBPA162372878
ChEMBLCHEMBL1421